Clinitude Clinical Services, a growing and innovative full-service Contract Research Organization (CRO), announced a strategic collaboration with Oracle Life Sciences, a global leader in cloud-based clinical data management and analytics solutions. This collaboration will enable Clinitude to leverage Oracle Life Sciences’ platform to streamline clinical data management services and maximize operational output. Clinitude selected Oracle Clinical One in January 2023 for its advanced data collection, randomization, and trial supply management (EDC & RTSM) capabilities.
With the Oracle Clinical One unified platform and built-in data analytics, Clinitude has reinforced an already robust data management process, optimized data collection for clinical trial sites, and augmented clinical data quality. By bringing these products together, Clinitude can speed time-to-market and efficiency for new projects without compromising study data reliability. This collaboration can provide customers with extraordinary data management services that will help accelerate the development of novel therapies to bring healthcare treatments to society faster.
Furthermore, Clinitude is engaged in Oracle’s CRO Growth Initiative to showcase the company’s services and clinical trial solutions at a global scale.
“By teaming up with Oracle Life Sciences and selecting its Clinical One platform, we will be able to maintain our focus on customer experience at Clinitude,” said Sabrina Wijnen, CEO, Clinitude. “This collaboration highlights our commitment to delivering extraordinary innovative services to our clients and demonstrates our devotion to advancing the clinical research industry in its entirety.”
“The Clinitude and Oracle collaboration is one of the significant strides we undertook this year to broaden our capabilities in forging tailor-made clinical trial solutions for our clients. This collaboration highlights the company’s vision in the delivery of innovative and dynamic clinical trial services,” added Sabrina.
“With increasing complexity within our industry, sponsors want to work with CROs who understand their needs and can provide better control of the data, processes, costs, and timelines to improve all stakeholder experiences and outcomes,” said Seema Verma, senior vice president and general manager, Oracle Life Sciences. “By selecting Clinical One, Clinitude is ready to support innovative clinical trial designs and the specific needs of its customers using our best-in-class technology.”
This strategic collaboration reinforces Clinitudes’ commitment to providing exceptional clinical trial services to its clients and accelerating the development of innovative therapies. We are excited about the opportunity to collaborate with Oracle Life Sciences and spearhead industry-leading innovation and operational excellence in the field of clinical data management.
*Oracle Logo is registered trademark of Oracle Corporation